Homepage Banner

Contact Lilly

If you wish to report an adverse event (side effect) or product complaint with a Lilly product, please call Lilly UK on 01256 315 000 (UK) or 016640446 (Ireland). Additionally reporting forms for adverse events and further information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store (UK) or www.hpra.ie (Ireland).

Report adverse event

Contact Lilly

If you wish to report an adverse event (side effect) or product complaint with a Lilly product, please call Lilly UK on 01256 315 000 (UK) or 016640446 (Ireland). Additionally reporting forms for adverse events and further information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store (UK) or www.hpra.ie (Ireland).

Report adverse event

Taltz®▼(Ixekizumab)

More information about Taltz coming soon...

Taltz is a targeted IL-17a inhibitor with high binding affinity (kd<3 pM).




Taltz, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drug (DMARD) therapies




Until then, please access our Summary of Product Characteristics here: https://www.medicines.org.uk/emc/product/7233/smpc




And our Prescribing information, by clicking here




Adverse events and product complaints should be reported. Reporting forms and further information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store, or Ireland: www.hpra.ie. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000, or Lilly Ireland on 01 664 0446.




▼ This medication is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare Professionals are asked to report any suspected adverse reactions.

Was this page helpful ?